Background: Aspirin exacerbated respiratory disease (AERD) is a syndrome characterized by chronic hyperplastic rhinosinusitis, nasal polyposis, asthma and aspirin sensitivity. The mechanisms by which produce these manifestations of intolerance are not fully defined, the current research involve alterations in the metabolism of arachidonic acid, cyclooxygenase 1 (COX-1) inhibition and its deviation from substrate to the lipoxygenase (LO) pathway, inducing increased synthesis of leukotrienes (LT). Biological plausibility of this fact has led to the search for polymorphisms in genes responsible for LT synthesis however others factors such as genetics polymorphisms in proinflammatory cytokines like, IL1B and IL8 could be associated. Methods: 78 patients with AERD, 135 aspirin-tolerant asthma (ATA) and 134 healthy control subjects participated. All participants who underwent a simple spirometry, methacholine challenge and nasal challenge with Lysine-aspirin (L-ASA), both tests performed according to international guidelines. Peripheral blood was drawn by venipuncture, genomic DNA was obtained using the commercial BDtract DNA isolation kit. We selected 2 polymorphisms in 2 genes related to chronic inflammation rs16944 in IL1B, and rs4073 in IL8, Allelic discrimination of SNPs was performed by Real Time PCR (PCR-RT) on a 7300 Real Time PCR Systems. Statistical analysis was performed between groups of cases (AERD and ATA) versus control group with Epi-info v.6.04 by x2 test to identify the difference between the allele and genotype frequencies of each polymorphism made, considering a significant P value ,0.05, in addition to the calculation of odds ratios and confidence intervals of 95%. Results: We find no association between IL1B (rs16944) to GG and GA genotypes in ATA patients versus control group neither AERD versus control group. Interestingly, the AA genotype showed increased frequency in the AERD patients versus the ATA patients (FG ¼ 0.19 versus 0.07), this association remained significant (P ¼ 0.018, OR 2.98, CI, 1.17-7.82). Conclusions: This is the first observation that IL1B polymorphisms are involved in AERD, suggest that patients carrying out the IL1B-511 polymorphism (rs16944 AA genotype) may show enhanced susceptibility to develop AERD. Background: Aspirin-exacerbated respiratory disease (AERD) refers to the development of bronchoconstriction in asthmatics following the ingestion of aspirin. Although alterations in eicosanoid metabolites play a role in AERD, other immune or inflammatory mechanisms may be involved. We aimed to identify proteins that were differentially expressed in nasal polyps between patients with AERD and aspirin-tolerant asthma (ATA). Methods: Two-dimensional electrophoresis was adopted for differential display proteomics. Proteins were identified by liquid chromatographytandem mass spectrometry (LC-MS). Western blotting and immunohistochemical staining were performed to compare the amount of fatty acidbinding protein 1(FABP1) in the nasal polyps of patients with AERD and ATA. Results: Fifteen proteins were significantly up-(7 spots) or down-regulated in the nasal polyps of patients with AERD (n ¼ 5) compared to those with ATA (n ¼ 8). LC-MS revealed an increase in 7 proteins expression and a decrease in 8 proteins expression in patients with AERD compared to those with ATA (P ¼ 0.003-0.045). FABP1-expression based on immunoblotting and immunohistochemical analysis was significantly higher in the nasal polyps of patients with AERD compared to that in patients with ATA. FABP1 was observed in epithelial, eosinophils, macrophages, and the smooth-muscle cells of blood vessels in the polyps. Conclusions: Our results indicate that alterations in 15 proteins, including FABP1, may be related to the development of AERD.
2 Respiratory and allergy, Soonchunhyang University Bucheon Hospital, Bucheon, South Korea. Background: Aspirin-exacerbated respiratory disease (AERD) refers to the development of bronchoconstriction in asthmatics following the ingestion of aspirin. Although alterations in eicosanoid metabolites play a role in AERD, other immune or inflammatory mechanisms may be involved. We aimed to identify proteins that were differentially expressed in nasal polyps between patients with AERD and aspirin-tolerant asthma (ATA). Methods: Two-dimensional electrophoresis was adopted for differential display proteomics. Proteins were identified by liquid chromatographytandem mass spectrometry (LC-MS). Western blotting and immunohistochemical staining were performed to compare the amount of fatty acidbinding protein 1(FABP1) in the nasal polyps of patients with AERD and ATA. Results: Fifteen proteins were significantly up-(7 spots) or down-regulated in the nasal polyps of patients with AERD (n ¼ 5) compared to those with ATA (n ¼ 8). LC-MS revealed an increase in 7 proteins expression and a decrease in 8 proteins expression in patients with AERD compared to those with ATA (P ¼ 0.003-0.045). FABP1-expression based on immunoblotting and immunohistochemical analysis was significantly higher in the nasal polyps of patients with AERD compared to that in patients with ATA. FABP1 was observed in epithelial, eosinophils, macrophages, and the smooth-muscle cells of blood vessels in the polyps. Background: Substantial data have demonstrated that air pollution is associated with cardiopulmonary mortality and morbidity in the world. Among a variety of pollutants, particulate components, particularly PM2.5, are especially suggested to be harmful to our lung health. Diesel exhaust particles (DEPs) are the major component of PM2.5, and therefore the relationship between PM2.5 or PM10 and airway inflammatory responses of asthmatic and people of not-yet asthma onset is important to be investigated. Recent findings suggested that susceptibility to DEPs is dependent upon certain genetic variations of anti-oxidative stress enzymes such as GSTP1, which is largely regulated by a transcription factor Nrf2. By preliminary experiments, we found that exhaled breath condensates (EBC) are safely and repeatedly obtained from both disease and health persons, and that several biomarkers including growth factors, cytokines and oxidant stress markers could be measured. Methods: In the present study, we attempted to study the airway inflammatory/fibrogenic responses from patients with asthma, and further, those from people who have suggestive, but not yet definite symptoms of asthma. Participants are asked to present exhaled breath condensates (EBC) by R-tubes during spontaneous breathing for 5 minutes, which are processed to measure several inflammatory/fibrogenic markers. Results: These molecules, including vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), basic fibroblast growth factor (FGF), IL-1 receptor antagonist, IL-8 and epidermal growth factor (EGF) tended to be increased in asthmatic group. These markers were significantly increased in severity step 4 patients as compared to mild asthmatics. There was a significant correlation between the PM10 concentration 1 month before the sampling of EBC and EBC EGF concentration. NO2 concentration and several markers in EBC in patients with asthma correlated with each other. EBC pH showed a significant relationship with the distance from main traffic roads. Conclusions: These results suggested that mass screening using simple methods such as EBC and appropriate biomarkers might facilitate the progress in the prophylaxis against hazardous health effects of DE exposures in subjects with high susceptibility to DEPs. This work was supported in part by a grant from Environmental Restoration and Conservation Agency of Japan.
The Relationship Between Maternal Atopy and Childhood Asthma
Salome Abbott, MD, and Robin Green, PhD. Department of Paediatrics, University of Pretoria, Pretoria, South Africa. Background: The diagnostic difficulty of childhood asthma leads to widespread under-diagnosis, which negatively affects the quality of life of asthmatic children. The presence of atopy in children is often used as a clinical tool to assist in making the diagnosis. However, local studies have demonstrated that atopy occurs in fewer asthmatic children than previously thought. This brings into question the association between allergy and asthma. The purpose of this study was to determine if a family history of allergy is predictive of atopic asthma in children, by comparing allergy, history of asthma and allergic symptoms, in mothers of atopic versus nonatopic asthmatic children. Methods: A random sample of children and their mothers attending the Children's Chest and Allergy Clinic at Steve Biko Academic Hospital were enrolled. Skin-prick testing or radioallergosorbent test results, of the children were obtained from the child's hospital records. Mothers completed a detailed questionnaire which included demographic details, a history of symptoms suggestive of 'atopy' and allergic diseases and a history of asthma. Skin prick testing was performed on the mothers. Results: 100 children and their parents were enrolled. 64 mothers to atopic children were used as the study group and 36 mothers to non-atopic children were used as the control group. Of the 48 mothers with a positive skin prick test, 30 (64%) had atopic children (P ¼ 0.836). Of the 16 mothers with asthma, 14 (88%) had atopic children (P ¼ 0.045). Of the 70 mothers with a history of symptoms suggestive of an allergic disease, 45 (64%) had children with atopic asthma (P ¼ 1.0). Of the 77 mothers who were considered to be allergic, 50 (65%) had children with atopic asthma (P ¼ 0.806). Conclusions: Both maternal skin prick positivity and a history of symptoms suggestive of allergic disease, are poor predictors of atopic asthma in children. This is true even in the mothers were considered to be allergic. However maternal asthma is a specific predictor of childhood atopic asthma with a good positive predictive and a high odds ratio. Further studies need to be conducted to compare the epidemiology of allergic asthma in different population groups. Background: The prevalence of asthma is high, the worldwide average being estimated at 10%, which makes it a public health problem. Many studies show a clear relationship between asthma and specific allergens. With sensitization to aeroallergens identified as a dominant risk factor for asthma. Objective: The present study of asthma reports the allergic sensitization of patients with severe persistent asthma followed in the Division of Clinical Immunology and Allergy of University of São Paulo Medical School. Methods: A total of 61 patients with severe persistent asthma defined according to the criteria of the Global Initiative for Asthma (GINA) were enrolled. Total IgE levels (IU/mL) were measured in serum and levels up to 120 IU/mL were considered within normal range. A battery of 7 aeroantigens (Dermatophagoides pteronyssinus, Blomia tropicalis, Aspergillus fumigatus, Penicillium nonatum, Lolium perenne, Felis domesticus, Canis familiaris, Blatela germanica and Periplaneta americana) was used in skin prick tests (SPTs), which were performed in each subject, on the volar side of the forearm. Histamine hydrochloride and normal saline solutions were used as positive and negative controls, respectively. The SPTs were read after 15 minutes and, a wheal at least 3 mm greater than the negative control was considered positive. Results: The asthmatic patients had a mean age of 48 years and 75% were female. We found that mean total serum IgE levels were 518.4 IU/mL (between 17 and 4720 UI/mL). SPTs positivity was 91.8% for D pteronyssinus, 67.2% for Blomia tropicalis, 4.9% for P nonatum and A fumigatus, 6.5% L perene and Felis domesticus, 16.3% for Canis familiaris, 21.3% Blatela germanica, 13.1% for Periplaneta americana. Twelve patients were monosensitized and 23 patients were polysensitized to 3 or more allergens. Conclusions: Most patients with severe allergic asthma were polysensitized, and dust mites, followed by cockroaches, were the main allergens. 
